BAB 1 dafpus

1. Duley L. The global impact of pre-eclampsia and eclampsia. Seminars in

Perinatology, 2009 Jun;33(3):130137.
2. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia.
Lancet, 2010, 21;376(9741):63144.
3. Khan KS, Wojdyla D, Say L, Glmezoglu AM, Van Look PF. WHO analysis of
causes of maternal death: a systematic review. Lancet, 2006 Apr
1;367(9516):10661074.
4. Campbell OM, Graham WJ; Lancet Maternal Survival Series steering group.
Strategies for reducing maternal mortality: getting on with what works.
Lancet, 2006, 368 (9543): 12841299.
5. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, dkk, editor.
Williams Obstetrics. Ed 23. [e-book]. New York: McGraw-Hill, 2010.
6. HladunewichM, Karumanchi SA, Lafayette R. Pathophysiology of the clinical
manifestations ofPreeclampsia. Clin J Am Soc Nephrol.2007;2:543-9.
7. LaMarca BD, Ryan MJ, Granger JP. Pathophysiology of hypertension during
preeclampsia:

role

ofinflammatory

cytokines.

Current

Hypertension

Reviews.2007;3:69-74.
8. Gestational hypertension and preeclampsia. In: Leveno KJ et al, editor.
Williams manual of obstetrics. New York: McGraw-Hill; 2003. hal.3414.
9. Sibai BM. Diagnosis and management of gestational hypertension and
preeclampsia. Obstet Gynecol. 2003;102:18192.
10.Coetzee EJ, Dommisse J, Anthony J. A randomized controlled trial of
intravenous magnesium sulfate versus placebo in the management of women
with severe preeclampsia. Br J Obstet Gynaecol 1998;105:3003.
11.Livingston JC, Livingston LW, Ramsey R, Mabie BC, Sibai BM. Magnesium
sulfate in women with mild pre-eclampsia: A randomized, double blinded,
placebo-controlled trial. Obstet Gynecol. 2003;101:21720.
12.Von Dadelzen P, Menzies J, Gilgoff S, Xie F, Douglas MJ, Sawchuck D, et al.
Evidence-based management for preeclampsia. Front Biosci. 2007;12:287689.
13.Tannirandorn Y. Is magnesium sulfate for prevention oronly therapeutic in
preeclampsia? J Med Assoc Thai.2005;88(7):1003-8.
14.Rumbold A, Duley L, Crowther CA, Haslam RR. Antioxidants for preventing
pre-eclampsia. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD004227.

15.WHO Vitamin C and Vitamin E trial group. World Health Organisation

multicentre randomised trial of supplementation with vitamins C and E
among pregnant women at high risk for pre-eclampsia in populations of low
nutritional status from developing countries. BJOG. 2009;116(6):780-8.
16.